Senior Scientist, CMC Developability

At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

Role

We are looking for a Senior Scientist in CMC Developability to join our Drug Product Development organization within CMC – Product Development. This role is ideal for a scientifically strong leader who enjoys bridging discovery insights with robust CMC decision-making.

In this position, you will be responsible for driving developability activities to support early and late-stage projects, with a strong focus on risk assessment and data-based decision making. You will lead and develop a small team of research analysts while working closely with Discovery and other CMC functions.

Responsibilities

• Act as the CMC Developability representative in cross-functional project teams, including regular interaction with Discovery teams

• Lead developability strategy and execution to support project progression and de-risking

• Plan, prioritize, and oversee laboratory activities, ensuring high scientific quality and timely delivery

• Manage and mentor a team of 3–4 research analysts, fostering scientific growth and accountability

• Analyze, interpret, and present experimental data to project teams and stakeholders

• Integrate historical and platform data to support informed, data-driven decisions across the portfolio

• Contribute to the continuous improvement of developability workflows, methods, and data usage

Requirements

• PhD (or equivalent experience) in biochemistry, biotechnology, pharmaceutical sciences, or a related field with at least 3 years of relevant experience in industry.

• Strong background in biochemical, biophysical, and analytical methods relevant to developability assessment

• Demonstrated expertise in chromatographic, spectroscopic and capillary techniques (e.g., SEC, IEX, HIC, CE-SDS, icIEF, A280 etc)

• Solid experience with stability and developability analyses, including thermal stability (Tm), aggregation propensity (Tagg), and stress studies

• Working knowledge of mass spectrometry data and its relevance for molecule characterization.

• Expertise in data analysis using statistical software (JMP)

• Proven ability to work with complex datasets and translate results into actionable, risk-based recommendations.

• Integrate and curate developability data across projects, building and maintaining a structured data bank of historical and current results

• Identify correlations, trends, and critical parameters across datasets to enable comparative assessments between new and legacy projects

• Experience leading or mentoring scientists in a laboratory environment

• Strong communication skills, with the ability to clearly present and defend data-driven conclusions in multidisciplinary settings

• Collaborative mindset and comfort working at the interface between Discovery and CMC
  

About You

• You are genuinely passionate about our purpose

• You bring precision and excellence to all that you do

• You believe in our rooted-in-science approach to problem-solving

• You are a generous collaborator who can work in teams with a broad spectrum of backgrounds

• You take pride in enabling the best work of others on the team

• You can grapple with the unknown and be innovative

• You have experience working in a fast-growing, dynamic company (or a strong desire to)

• You work hard and are not afraid to have a little fun while you do so!

Locations

Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are crafted as open, community-based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you’re in one of our office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X .

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com) .

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the contract.